Home » Stocks » HIMS

Hims & Hers Health, Inc. (HIMS)

Stock Price: $7.91 USD -0.02 (-0.25%)
Updated Jul 30, 2021 4:00 PM EDT - Market closed
After-hours: $8.08 +0.17 (2.15%) Jul 30, 7:35 PM
Market Cap 1.58B
Revenue (ttm) 201.07M
Net Income (ttm) -70.85M
Shares Out 153.08M
EPS (ttm) -0.59
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 30
Last Price $7.91
Previous Close $7.93
Change ($) -0.02
Change (%) -0.25%
Day's Open 7.90
Day's Range 7.77 - 8.17
Day's Volume 2,448,461
52-Week Range 7.77 - 25.40

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to ...

1 week ago - Business Wire

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers releases survey findings on the pandemic's impact on Americans' mental health.

2 weeks ago - Business Wire

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers releases survey findings on the pandemic's impact on Americans' mental health.

2 weeks ago - Business Wire

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company,” NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellnes...

3 weeks ago - Business Wire

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers expands focus on sexual health with new product bundles.

3 weeks ago - Business Wire

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers has finalized the acquisition of teledermatology specialist, Apostrophe.

3 weeks ago - Business Wire

The potential for expansion coupled with a highly competitive pharmacy market has a BofA Securities analyst sidelined on shares of Hims & Hers Health, Inc. (NYSE:HIMS). The Hims Analyst: Michael Cherny ...

3 weeks ago - Benzinga

Urban Outfitters (URBN) partners with Hims & Hers Health to offer personalized wellness offerings to customers.

Other stocks mentioned: URBN
4 weeks ago - Zacks Investment Research

When Urban Outfitters announced a new partnership with direct-to-consumer health and wellness brand Hims & Hers, one way to look at it was simply an effort to get more diverse product offerings on the l...

Other stocks mentioned: URBN
4 weeks ago - PYMNTS

After dabbling with group therapy during the pandemic, the telehealth company has decided to launch one-on-one teletherapy for $99 per session. Telehealth provider Hims & Hers is launching teletherapy s...

4 weeks ago - Fast Company

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers expands mental health offerings to include one-on-one online therapy services.

4 weeks ago - Business Wire

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers has partnered with Urban Outfitters, starting with the availability of select Hims products on urbanoutfitters.com.

Other stocks mentioned: URBN
1 month ago - Business Wire

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers acquires teledermatology specialist Apostrophe to deepen investment in dermatology.

1 month ago - Business Wire

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers expands hair growth offerings with launch of Minoxidil 5% Foam, offering more choice and less stigma around hair loss.

1 month ago - Business Wire

The stock price for each of these companies dropped more than 5% on Tuesday.

Other stocks mentioned: PRTS, VRM
1 month ago - The Motley Fool

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers has been named D-To-C Brand of The Year By Ad Age in the publication's A-List & Creativity Awards 2021.

1 month ago - Business Wire

Multispecialty telehealth platform Hims & Hers will acquire London-based health program Honest Health, which works in hair-loss-related products, a press release said Monday (June 14). With the acquisit...

1 month ago - PYMNTS

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers To Expand UK Footprint, Acquire London-Based Honest Health

1 month ago - Business Wire

A telehealth and health and wellness company that recently went public announced a new deal with platinum artist Miley Cyrus. What Happened: Miley Cyrus is joining as a creative advisor for Hims & Hers ...

1 month ago - Benzinga

Money has been flowing out of AMC Entertainment and into these up-and-coming short-squeeze candidates.

Other stocks mentioned: WISH
1 month ago - The Motley Fool

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers has created an all-new treatment for hair loss that combines two of the most effective ingredients into a single spray.

1 month ago - Business Wire

Following their sector-wide correction, shares in these nine SPACs and former SPACs have fallen to an attractive entry point. The post 9 SPACs to Buy After the Selloff appeared first on InvestorPlace.

Other stocks mentioned: APXT, FSR, GHVI, GNOG, NEBC, PSFE, RAAC ...
2 months ago - InvestorPlace

Looking for cheap telemedicine stocks on the move? Look no further.

Other stocks mentioned: AMWL, TDOC
2 months ago - The Motley Fool

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, will hold its vi...

2 months ago - Business Wire

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today reported f...

2 months ago - Business Wire

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today announced ...

2 months ago - Business Wire

Shares of Hims & Hers Health, Inc. (NYSE:HIMS) are in trouble. The stock is testing critical support and if this support holds, shares may rally.

3 months ago - Benzinga

Here are three companies with exciting growth stories that just went public.

Other stocks mentioned: BMBL, RBLX
3 months ago - The Motley Fool

These companies are at the forefront of innovation in the healthcare sector, and their stocks are surprisingly affordable too.

Other stocks mentioned: PFE, YI
3 months ago - The Motley Fool

Ignore the near-term pullback in Hims & Hers. With its unique business model, telehealth play HIMS stock remains a potential long-term winner.

3 months ago - InvestorPlace

Hims & Hers CEO on portfolio expansion opportunities, company outlook

YouTube video

Yahoo Finance's Brian Sozzi, Myles Udland, and Julie Hyman speak with Hims & Hers Co-founder & CEO Andrew Dudum about the company's first earnings report since going public.

4 months ago - Yahoo Finance

Shares of the newly public company dropped on weak guidance in its fourth-quarter earnings report.

4 months ago - The Motley Fool

There are a lot of crosscurrents in the market right now.

Other stocks mentioned: FDX
4 months ago - The Motley Fool

Multi-specialty telehealth platform Hims & Hers Health, Inc. reported that revenue surged 67 percent from the fourth quarter of 2019 to the fourth quarter of 2020. “This is an organization built on soli...

4 months ago - PYMNTS

Hims & Hers Health Inc. (NYSE: HIMS) reported its financial results for the fiscal fourth quarter on Thursday that came in better than what analysts had anticipated, despite the ongoing Coronavirus pand...

4 months ago - Invezz

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today reported f...

4 months ago - Business Wire

SAN FRANCISCO--(BUSINESS WIRE)--Andrea Perez and Ambar Bhattacharyya join Hims & Hers Board of Directors to help the company pioneer a better way for patients to access healthcare.

4 months ago - Business Wire

A small company by the name of Conversion Labs (NASDAQ:CVLB) will be the eBay or Alibaba of the DTC telemedicine platforms space. The post This DTC Telemedicine Stock Has Enormous Potential Thanks to th...

Other stocks mentioned: CVLB
5 months ago - InvestorPlace

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, will participate...

5 months ago - Business Wire

SPACs dominated Wall Street in 2020. The backwards IPOs of these three companies suggests that 2021 will be more of the same.

Other stocks mentioned: APPH, GMTX
5 months ago - InvestorPlace

Telehealth is the future, and Hims & Hers looks well-positioned for that future. Growth should keep the rally in HIMS stock going.

5 months ago - InvestorPlace

The prospects for HIMS stock look good. The company has certainly built a robust platform.

5 months ago - InvestorPlace

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, will release fis...

5 months ago - Business Wire

If you believe in the future of telemedicine, then keep an eye on HIMS stock. It might not be in the buy zone yet, though, so be patient.

5 months ago - InvestorPlace

The company has had early success in building a customer base as well as infrastructure to support their demand. HIMS offers frictionless patient to consumer experiences that are cost efficient and comp...

5 months ago - Seeking Alpha

With its focus on millennials, fast growing telemedicine play HIMS stock has plenty of room to run after its recent SPAC merger. The post Buy Hims & Hers Stock for a Solid Play on Telehealth appeared fi...

6 months ago - InvestorPlace

Hims & Hers CEO on $1.6 billion SPAC deal and goal to provide affordable health care

YouTube video

Hims & Hers Co-Founder and CEO Andrew Dudum joins Yahoo Finance's Brain Sozzi and Julie Hyman to discuss the company's $1.6 billion SPAC deal with Oaktree Capital Management and discuss the future of me...

6 months ago - Yahoo Finance

Hims & Hers, a San Francisco-based telehealth startup that sells sexual wellness and other health products and services to millennials, began trading publicly today on the NYSE after completing a revers...

Other stocks mentioned: OAC
6 months ago - TechCrunch

Telehealth play HIMS stock makes its debut today. Here's what you should know about newly public Hims & Hers now.

Other stocks mentioned: OAC
6 months ago - InvestorPlace

About HIMS

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's cu... [Read more...]

Industry
Household & Personal Products
Founded
2017
Stock Exchange
NYSE
Ticker Symbol
HIMS
Full Company Profile

Financial Performance

In 2020, HIMS's revenue was $148.76 million, an increase of 80.18% compared to the previous year's $82.56 million. Losses were -$18.11 million, -74.86% less than in 2019.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for HIMS is 13.80, which is an increase of 74.46% from the latest price.

Price Target
$13.80
(74.46% upside)